Savant Capital Management »

Kalvista Pharmaceuticals shares owned by Savant Capital Management

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Savant Capital Management from 13F filings

Historical chart of Savant Capital Management investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Savant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Savant Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $141k 12k 12.18

More positions owned by Savant Capital Management

American Centy Etf Tr Avantis Emgmkt (AVEM)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Vanguard Index Fds Total Stk Mkt (VTI)
Dimensional Etf Trust Intl High Profit (DIHP)
Dimensional Etf Trust Us Mktwide Value (DFUV)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Dimensional Etf Trust Us Large Cap Val (DFLV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Dimensional Etf Trust Internatnal Val (DFIV)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Global Real Est (DFGR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Savant Capital Management

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Tang Capital Management
Frazier Life Sciences Management
Suvretta Capital Management
Capital World Investors
BlackRock
Vanguard Group
Millennium Management
Woodline Partners
Goldman Sachs Group
Parkman Healthcare Partners
Caption Management
State Street Corporation
Silverarc Capital Management
Emerald Advisers

View all funds holding Kalvista Pharmaceuticals